# DIAgnostics for Multidrug Resistant Tuberculosis in Africa

> **NCT03303963** · — · COMPLETED · sponsor: **Dissou AFFOLABI** · enrollment: 3356 (actual)

## Conditions studied

- Tuberculosis, Multidrug-Resistant

## Interventions

- **DIAGNOSTIC_TEST:** Deeplex test, MolBio TrueNat for 2nd line, GeneXpert 2nd line
- **DIAGNOSTIC_TEST:** Fluorescein DiAcetate (FDA) Microscopy,GeneXpert Ct value, pre-rRNA synthesis

## Key facts

- **NCT ID:** NCT03303963
- **Lead sponsor:** Dissou AFFOLABI
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-05-04
- **Primary completion:** 2022-06-30
- **Final completion:** 2022-11-30
- **Target enrollment:** 3356 (ACTUAL)
- **Last updated:** 2023-03-14

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03303963

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03303963, "DIAgnostics for Multidrug Resistant Tuberculosis in Africa". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03303963. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*